Home

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (DNA)

8.2600
0.00 (0.00%)

Ginkgo Bioworks is a biotechnology company that focuses on the design and engineering of microbial strains for various applications across diverse industries, including pharmaceuticals, agriculture, and industrial biotechnology

By leveraging advanced genetic engineering and synthetic biology techniques, Ginkgo aims to create custom organisms that can produce valuable ingredients, enhance agricultural yields, or contribute to sustainable manufacturing processes. The company operates through a platform model, allowing collaborations with partners to transform biological systems into efficient and scalable solutions that address real-world challenges, all while paving the way for a future with more sustainable and tailored biological products.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close8.260
Open-
Bid8.150
Ask8.200
Day's RangeN/A - N/A
52 Week Range5.260 - 51.20
Volume3,572
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume2,246,481

News & Press Releases

Flywire Posts Downbeat Results, Joins Lemonade, Ginkgo Bioworks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · February 26, 2025
US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&P 500's Four-Day Fall Was A 'Non-Event,' Says Expertbenzinga.com
U.S. stock futures rose on Wednesday following two consecutive days of mixed close this week. All futures advanced in premarket trading.
Via Benzinga · February 26, 2025
Why ZoomInfo Technologies Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · February 26, 2025
Earnings Scheduled For February 25, 2025benzinga.com
Via Benzinga · February 25, 2025
Earnings Scheduled For November 12, 2024benzinga.com
Via Benzinga · November 12, 2024
Insights into Ginkgo Bioworks Holdings's Upcoming Earningsbenzinga.com
Via Benzinga · November 11, 2024
From Promise to Peril: The Downfall of Ginkgo Bioworksbenzinga.com
Via Benzinga · August 26, 2024
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarketbenzinga.com
Via Benzinga · February 6, 2025
What's Going On With Ginkgo Bioworks Stock This Week?benzinga.com
Ginkgo Bioworks Holdings Inc (NYSEDNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here's a look at what's going on.
Via Benzinga · September 18, 2024
Why Ginkgo Bioworks Holdings Stock Raced 9% Higher Todayfool.com
The company is forging ahead with next-generation drug development solutions.
Via The Motley Fool · September 17, 2024
Google Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Developmentbenzinga.com
Ginkgo Bioworks introduces a protein large language model and API, developed with Google Cloud, to streamline drug discovery by leveraging AI and proprietary biological data, offering affordable and accessible tools for researchers.
Via Benzinga · September 17, 2024
Ginkgo Bioworks Stock Is Rallying Tuesday: Here's Whybenzinga.com
Ginkgo Bioworks Holdings Inc (NYSEDNA) shares are surging Tuesday after the company announced the launch of its new protein large language model (LLM) built on Google Cloud.
Via Benzinga · September 17, 2024
Compass Minerals, Torrid Holdings, Icahn Enterprises, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · September 17, 2024
Down a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?fool.com
Could this beaten-down stock turn things around in the near future?
Via The Motley Fool · September 5, 2024
2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stockfool.com
The risks may resolve in a year or so but seizing the opportunities will take longer.
Via The Motley Fool · September 3, 2024
This 1 AI Stock Could Revolutionize Biotech and Pharmafool.com
The company is using artificial intelligence, and planning to help others use AI empowered by its data collection.
Via The Motley Fool · September 2, 2024
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?fool.com
Its ambitious business model may not be sustainable.
Via The Motley Fool · August 24, 2024
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?fool.com
Have shares of the troubled life sciences business fallen too far?
Via The Motley Fool · August 15, 2024
Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocksfool.com
Efficiency in core processes is set to increase substantially due to AI.
Via The Motley Fool · August 13, 2024
DNA Stock Earnings: Ginkgo Bioworks Holdings Misses EPS, Beats Revenue for Q2 2024investorplace.com
DNA stock results show that Ginkgo Bioworks Holdings missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024
DNA Stock Alert: Ginkgo Bioworks Plunges on Plan for Reverse Stock Splitinvestorplace.com
Ginkgo Bioworks stock is falling hard on Friday as DNA investors prepare to vote on a reverse stock split later this month.
Via InvestorPlace · August 2, 2024
7 Meme Mania Stocks: Which Are FOMO and Which Are Free Money?investorplace.com
Which of these 7 meme stocks are likely to punish investors and which are likely to provide free money? Read on to see.
Via InvestorPlace · July 23, 2024
7 Sorry Biotech Stocks Set to Make Investors Sadinvestorplace.com
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Via InvestorPlace · July 22, 2024
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buyinvestorplace.com
Ginkgo Bioworks has multiple, positive catalysts that can make the low valuation of Ginkgo Bioworks stock melt up. 
Via InvestorPlace · July 18, 2024
DNA Stock: Ginkgo Bioworks Announces New Collaborationinvestorplace.com
Although Ginkgo Bioworks’ partnership with an agricultural innovator boosted DNA stock, the company still faces challenges.
Via InvestorPlace · July 16, 2024